In vivo 19F MRI for Cell Tracking
November 25th, 2013
14.8K views
We describe a general protocol for in vivo cell tracking using MRI in a mouse model with ex vivo labeled cells. A typical protocol for cell labeling, image acquisition processing and quantification is included.
Overview
This article describes a protocol for in vivo cell tracking using MRI in a mouse model with ex vivo labeled cells. The procedure focuses on imaging and quantifying 19F labeled cells in vivo, which can be applied in both clinical and preclinical settings.
Key Study Components
Area of Science
- Neuroscience
- Imaging Techniques
- Cell Tracking
Background
- In vivo imaging is crucial for understanding cell behavior in living organisms.
- 19F MRI allows for non-invasive tracking of labeled cells.
- Ex vivo labeling of cells is a common practice to prepare them for imaging.
- Quantification of labeled cells is essential for accurate analysis.
Purpose of Study
- To develop a reliable method for tracking 19F labeled cells in vivo.
- To quantify the 19F content per cell using MRI techniques.
- To provide a protocol that can be utilized in various research settings.
Methods Used
- Labeling cells with a suitable 19F agent ex vivo.
- Using 19F MRI for imaging the labeled cells in vivo.
- Quantifying 19F content per cell with a known reference.
- Calculating correction factors if 19F content varies during the experiment.
Main Results
- The protocol successfully tracks 19F labeled cells in vivo.
- Quantification methods yield reliable data on cell content.
- The study demonstrates the feasibility of using 19F MRI in both clinical and preclinical settings.
- Correction factors can be applied when necessary to maintain accuracy.
Conclusions
- The developed protocol enhances the ability to track and quantify cells in vivo.
- 19F MRI is a valuable tool for researchers in cell tracking studies.
- Future applications may expand to various fields within neuroscience and biology.
Frequently Asked Questions
What is the main goal of this protocol?
The main goal is to image and quantify 19F labeled cells in vivo using MRI.
How are the cells labeled for tracking?
Cells are typically labeled ex vivo with a suitable 19F agent.
Can this method be used in clinical settings?
Yes, the protocol can be applied in both clinical and preclinical settings.
What is the significance of quantifying 19F content per cell?
Quantifying 19F content is essential for accurate analysis of cell behavior.
What should be done if 19F content varies during the experiment?
Correction factors must be calculated to maintain accuracy in quantification.
Executive Industry Relevance
In vivo 19F MRI enables quantitative, non-invasive cell tracking without ionizing radiation, supporting preclinical and clinical applications in cellular therapeutics. The method provides direct quantification of labeled cells from image data, reducing confounding background signals compared to conventional MRI techniques. This capability enhances predictive confidence in biodistribution studies and supports go/no-go decisions in cell therapy development pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by tracking immune cell localization and persistence in vivo.
- Operational Value: Supports biological de-risking through quantitative assessment of cell trafficking to target tissues.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream workflows by establishing reliable cell labeling and quantification protocols.
- Operational Value: Addresses assay standardization and reproducibility through defined 19F content per cell measurements and reference-based calibration.
Translational & Preclinical Research
- Scientific Value: Describes continuity from discovery through preclinical validation by enabling longitudinal tracking of transferred cells in animal models.
- Operational Value: Supports risk-adjusted advancement decisions by providing quantitative data on cell numbers and localization over time.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from hypothesis testing through lead identification to preclinical validation, supporting iterative refinement of cell therapy candidates.
- Discovery Biology: Explains how the method supports hypothesis testing, pathway clarification, and biological de-risking via direct cell quantification.
- Screening: Describes assay readiness, reproducibility, and quantitative outputs through 19F MRI signal proportionality to cell number.
- Analytics: Highlights measurements, readouts, or statistical outputs that help teams compare conditions across time points and treatment groups.
- Translational Research: Connects the method to preclinical continuity through longitudinal imaging studies in relevant disease models.
- Enterprise Reuse: Frames the method as a reusable capability for tracking diverse cell types across multiple projects and therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in cell fate studies.
- Operational Value: Standardization, reproducibility, and scalability across cell types, labels, and imaging platforms.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk in cell therapy development.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantitative biodistribution data.
Implementation Considerations
- Required scientific expertise in cell labeling, MRI physics, and image quantification.
- Instrumentation and analytical infrastructure needs including dual-tuned MRI systems and spectroscopy capabilities.
- Cross-team standardization requirements for labeling protocols, reference compounds, and image analysis pipelines.
- Adaptation considerations across model systems, cell types, and 19F labeling agents.
- Practical limitations including assumption of uniform 19F labeling per cell and need for validation with orthogonal methods.
Biopharma FAQs
Why does quantifying 19F content per cell matter for target validation?
Quantifying 19F content per cell enables direct calculation of cell numbers from MRI signal, which is essential for accurate assessment of therapeutic cell localization and persistence in vivo. This measurement supports target validation by providing quantitative biodistribution data that correlates with therapeutic mechanism and target engagement.
How does isolating the 19F signal from background fit the discovery pipeline?
Isolating the 19F signal eliminates confounding background from endogenous tissues, allowing specific detection of transferred labeled cells. This specificity fits the discovery pipeline by enabling clear readouts of cell trafficking without interference, supporting accurate hypothesis testing in early-stage target validation.
What quantitative dependent variable measurements enable cell number estimation?
Quantitative dependent variable measurements include 19F signal intensity from regions of interest, which is proportional to the number of fluorines present. When combined with the known 19F content per cell determined via NMR spectroscopy, these measurements enable direct estimation of transferred cell numbers in vivo.
Why do replication requirements matter for cross-functional collaboration?
Replication requirements ensure statistical significance in 19F content per cell measurements, which is necessary for reliable quantification across experiments. Consistent replication supports cross-functional collaboration by providing reproducible data that teams in discovery, preclinical, and translational science can trust for decision-making.
What statistical analysis capabilities are required before implementing 19F MRI for cell tracking?
Required statistical analysis capabilities include averaging repeated NMR spectroscopy measurements to determine mean 19F content per cell with confidence intervals. Additionally, proportionality analysis between 19F signal intensity and cell number requires validation through linear regression and error propagation to ensure accurate quantification from imaging data.
Chapters in this video
0:05
Title
2:00
Cell Labeling (Standard Protocol with Coincubation)
2:57
Determination of 19F/cell using 19F NMR
4:17
Imaging and Mouse Preparation
7:44
Image Processing
8:45
Results: 19F-labeled Cells Homing to a Draining Lymph Node
9:35
Conclusion
5:29
B1 Correction
